Mercy Tissue Engineering Ltd.

Autologous cell culture treatments and implants

Mercy Tissue Engineering (MTE) is a human tissue culture company that was established in Australia and Singapore in 1998. It was founded by Mercy Health and Aged Care and is located at St. Vincent’s and Mercy Private Hospital in Melbourne. MTE is ISO9001:2000 certified.

159 Grey Street
East Melbourne
Victoria 3002
Australia
Phone: +61-3-9928-6030
Fax: +61-3-9928-6033

MTE’s cartilage product for autologous chondrocyte transplantation (ACT) is marketed as Cartogen.

The company is also the distributor of Bio Nova Omniflow II (Bio Nova International Pty Ltd) vascular implants in Australia. These are collagen-based grafts designed for peripheral vascular reconstruction and anterior venous access.